Skip to content

MaxCyte MXCT Price / sales

Price / sales at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.9×+0.2×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
4.4×-0.8×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
2.7×+1.2×
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-0.8×
PDE
Pro-Dex, Inc.PDEX
2.1×-0.4×
Repligen logo
RepligenRGEN
13.2×-0.1×

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

Based on the most recent quarter.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's price / sales?
MaxCyte (MXCT) reported price / sales of 2.3× in Q1 2026.
How has MaxCyte's price / sales changed year-over-year?
MaxCyte's price / sales decreased by 69.7% year-over-year, from 7.7× to 2.3×.
What is the long-term trend for MaxCyte's price / sales?
Over 4 years (2021 to 2025), MaxCyte's price / sales has grown at a -36.3% compound annual growth rate (CAGR), from 30.5× to 5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.